Clinical Trial Update: A Phase 3 Trial of JKN2401 Injection in COPD [Phase 3]

View source ↗

Summary

Phase 3 trial update for JKN2401 Injection in chronic obstructive pulmonary disease (COPD); the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• JKN2401 Injection

Snippet

Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: NOT_YET_RECRUITING